Biogen, Inc. (BIIB)
201.18
+15.82
(+8.53%)
USD |
NASDAQ |
Feb 06, 16:00
197.28
-3.90
(-1.94%)
After-Hours: 20:00
Biogen Cash and Short Term Investments (Quarterly) : 3.816B for Dec. 31, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
| AbbVie, Inc. | -- |
| Stoke Therapeutics, Inc. | 248.31M |
| Alnylam Pharmaceuticals, Inc. | 2.725B |